No increased risk of cancer has been found compared to other implants but he pointed to the "well-known risk of rupture" and the irritative power of the gel filler which could lead to an inflammatoryreaction.
The healthy volunteers were testing an anti-inflammatory drug - TGN1412 - at a research unit based at Northwick Park Hospital when they suffered a severe reaction.